Sarissa Capital Management LP → Innoviva, Inc. INVA

Stake: 8.40% Shares: 5,237,161 CUSIP: 45781M101 Class: Common Stock, par value $0.01 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended by adding the following: The Reporting Persons may make additional sales of Common Stock or enter other transactions related to the Issuer's securities.

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 7.09

6,545,793 shares short · -4.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $2.27M

Point72 Asset Mgmt

Other 13D/G Filings on Innoviva, Inc.

Filed	Form	Filer	Stake	Shares
2025-03-17	SCHEDULE	Sarissa Capital Management LP	4.70%	2,966,022	view →
2018-04-10	SC	GLAXOSMITHKLINE PLC	—	—	view →

Other Filings by Sarissa Capital Management LP

Filed	Form	Issuer	Stake	Shares
2025-03-17	SCHEDULE	Innoviva, Inc. INVA	4.70%	2,966,022	view →
2018-04-03	SC	EMMAUS LIFE SCIENCES, INC.	—	—	view →
2018-03-23	SC	APRICUS BIOSCIENCES, INC.	—	—	view →
2018-03-19	SC	NOVELION THERAPEUTICS INC.	—	—	view →
2018-01-31	SC	APRICUS BIOSCIENCES, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →